Erythropoietin is a hormone produced primarily by capillary network of the kidney's renal cortex, with small amounts produced by liver and brain. It stimulates production of red blood cells (RBCs). Erythropoietin (EPO) is a protein generated by red blood cells. It is also known as hematopoietin or hemopoietin. Kidney cells produce and release erythropoietin when blood oxygen levels are extremely low. Erythropoietin drugs are used to treat anemia caused by chronic kidney disease (CKD), cancer, and human immunodeficiency virus (HIV). The report provides market dynamics and trends related to the global erythropoietin drugs market. The study estimates revenue generated from sales of erythropoietin products; however, it excludes total revenue for bio similar products. The valuations comprise revenue generated from erythropoietin products such as epoetinalfa, epoetin-beta, and darbepoetin-alfa.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET LANDSCAPE

CHAPTER 4: ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT TYPE

CHAPTER 5: ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION

CHAPTER 6: ERYTHROPOIETIN DRUGS MARKET, BY REGION

CHAPTER 7: COMPANY PROFILES